Mission:
Contributes to transition:
Contributes to SDG(s):
Driven by the protein transition, the global demand for products based on microalgae is growing rapidly. Food supplements, cosmetics and animal feed (aquaculture) are currently the main applications of microalgae.
Lgem produces and rents photobioreactors (also known as photobioreactors, or PBRs) for the cultivation of microalgae on an industrial scale and for a variety of commercial applications. The company's portfolio consists of sixty percent of customers and prospects who (will) produce food-related products based on microalgae.
“ROM InWest is taking a stake in Lgem because the company, with its photobioreactors, can be a catalyst for innovative applications of microalgae for more sustainable and healthy products,” explains Janet Nieboer, CEO of ROM InWest. “Thanks to their technological solutions and knowledge of algae cultivation, they are uniquely positioned to make the global food supply, aquaculture, animal feed, cosmetics and pharmaceutical industries healthier and more sustainable quickly and on a large scale.”

Globally, around 40 million people live with severe blindness. Phosphoenix is developing a brain implant (neuroprosthetic system) that can restore functional vision using AI in people who later in life...
Greencovery has a sustainable solution to reuse residual streams from the food industry and convert them into valuable ingredients. In this way, a cost item, waste processing of residual materials, is transformed into an extra...
Phoenix Metals is an innovative company that recovers valuable raw materials from industrial waste streams such as steel slag, thereby playing an innovative role in the battery market.
Root Sustainability develops AI technology that allows retailers to make smart decisions based on product-specific data to concretely reduce the CO2 footprint in their supply chain. Dispersed data is quickly and efficiently...
Methotrexate is currently the most commonly prescribed basic drug for rheumatoid arthritis worldwide. Sixty to eighty per cent of patients receive this drug. The problem, however, is that methotrexate is too...
Healthplus.ai is a Dutch MedTech scale-up from Amsterdam. Their AI system PERISCOPE® calculates each patient's risk of infection after surgery and gives the healthcare team clear actions to reduce that risk....
Subscribe to our newsletter and stay up to date with news, stories, relevant events and more.